ArticleNeurochemical research2025
Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is characterized by impairments in motor control following the degeneration of dopamine-producing neurons located in the substantia nigra pars compacta. Environmental pesticides such as Paraquat (PQ) and Maneb (MB) contribute to the onset of PD by inducing oxidative stress (OS). This study evaluated the therapeutic efficacy of moderate physical activity (PA) on both motor and non-motor symptoms in a Wistar rat model of Paraquat and Maneb (PQ/MB) induced PD. Thirty male Wistar rats were randomly divided into six groups: control, exercise (EX), PQ/MB, PQ/MB + L-dopa, PQ/MB + EX, and PQ/MB + EX + L-dopa. PD was induced via intraperitoneal (IP) injections of PQ (5 mg/kg) and MB (0.05 mg/kg) administered twice weekly for six weeks, followed by four weeks of moderate exercise in the designated groups. Motor and non-motor behaviors were then assessed, and OS markers were analyzed in the prefrontal cortex (PFC), striatum (ST), and hippocampus (HP). In our model, PQ/MB exposure induced characteristic PD symptoms, including motor dysfunction, anxiety, depression, and memory deficits. These symptoms were accompanied by elevated malondialdehyde (MDA) levels and reduced activity of antioxidant enzymes. However, moderate PA significantly improved several parameters: it enhanced coordination and balance, reduced anxiety and depressive-like behaviors, improved memory performance, attenuated lipid peroxidation, and increased antioxidant defense mechanisms, particularly the activity of catalase (CAT) and superoxide dismutase (SOD). These findings suggest that PA is a promising non-pharmacological therapeutic approach for the management of both motor and non-motor symptoms of PD.
Indexed as
Identifiers
40928730What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.